Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asher Mullard

Showing results (51-60 of 681) with videos related to

Pageof 69
Sort By:
Nature Reviews. Drug Discovery|February 12, 2021
Parkinson pipeline pare backAsher Mullard
Nature Reviews. Drug Discovery|March 12, 2021
FDA approves first anti-ANGPTL3 antibody, for rare cardiovascular indicationAsher Mullard
Nature Reviews. Drug Discovery|November 3, 2022
Two competing RSV vaccines round final phase III cornerAsher Mullard
Nature Reviews. Drug Discovery|September 9, 2025
Novel drug candidates for hard-to-treat hypertension vie for blockbuster positioningAsher Mullard
Nature Reviews. Drug Discovery|May 13, 2020
COVID umbrella trials multiplyAsher Mullard
Nature Reviews. Drug Discovery|May 20, 2021
Accelerated approvals under the microscopeAsher Mullard
Nature Reviews. Drug Discovery|September 7, 2021
Pfizer buys Trillium and its CD47 candidates for US$2.3 billionAsher Mullard
Nature Reviews. Drug Discovery|August 16, 2022
First de novo deuterated drug poised for approvalAsher Mullard
Nature Reviews. Drug Discovery|May 13, 2021
Malaria vaccine shows phase II promise, advances into phase IIIAsher Mullard
Nature Reviews. Drug Discovery|August 5, 2022
Pliant's integrin inhibitor boosted by phase II IPF dataAsher Mullard
Pageof 69

Showing results (51-60 of 681) with videos related to

Sort By:
Pageof 69
Nature Reviews. Drug Discovery|February 12, 2021
Parkinson pipeline pare backAsher Mullard
Nature Reviews. Drug Discovery|March 12, 2021
FDA approves first anti-ANGPTL3 antibody, for rare cardiovascular indicationAsher Mullard
Nature Reviews. Drug Discovery|November 3, 2022
Two competing RSV vaccines round final phase III cornerAsher Mullard
Nature Reviews. Drug Discovery|September 9, 2025
Novel drug candidates for hard-to-treat hypertension vie for blockbuster positioningAsher Mullard
Nature Reviews. Drug Discovery|May 13, 2020
COVID umbrella trials multiplyAsher Mullard
Nature Reviews. Drug Discovery|May 20, 2021
Accelerated approvals under the microscopeAsher Mullard
Nature Reviews. Drug Discovery|September 7, 2021
Pfizer buys Trillium and its CD47 candidates for US$2.3 billionAsher Mullard
Nature Reviews. Drug Discovery|August 16, 2022
First de novo deuterated drug poised for approvalAsher Mullard
Nature Reviews. Drug Discovery|May 13, 2021
Malaria vaccine shows phase II promise, advances into phase IIIAsher Mullard
Nature Reviews. Drug Discovery|August 5, 2022
Pliant's integrin inhibitor boosted by phase II IPF dataAsher Mullard
Pageof 69